Skip to main content
OpenTrials
Completed

NCT Number: NCT04428970

Intracranial Pressure (ICP) Monitoring Following Traumatic Brain Injury (TBI)

The aim of this retrospective cohort study is to evaluate complications rates, indications, and the utility of follow-up imaging studies of ICP measurement in severe TBI patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical Universtiy of Vienna

Vienna, A-1090, Austria

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Severe Traumatic Brain Injury (GCS<9 on arrival)
  • Implantation of invasive intracranial parenchymal ICP monitoring

Exclusion criteria

  • incomplete data records

Treatment and study plan

Invasive ICP monitoring

Procedure

Insertion of a parenchymal pressure measuring probe

Primary outcomes

  1. Complications

    Time frame: up to 30 days

    Intervention-related complications

Secondary outcomes

  1. Clinical outcome

    Time frame: up to 30 days

    Outcome at discharge measured by the Glasgow Outcome Scale (GOS), range 1(death) - 5 (good recovery)

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Official study title

Intracranial Pressure Monitoring Following Traumatic Brain Injury - Evaluation of Indications, Complications, and Significance of Follow-up Imaging.

Important dates

Study start
2007
Primary completion
2017
Study completion
2020
First posted
Jun 11, 2020
Registry last updated
Jan 26, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.